Abstract
This thesis demonstrates that the wide range of diseases caused by Group A Streptococcus (GAS) results in considerable health and economic burdens, both at the population level and throughout the lifetime of the individual. In the short-term, an economic case can be made for population-wide echocardiographic screening for rheumatic heart disease in remote Indigenous communities in the northern regions of Australia. However, a vaccine that reduces all GAS disease by 70% would be cost-effective at a price in line with other modern, publicly funded vaccines, with cellulitis and other skin infections being important targets in addition to throat infections.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 16 Jul 2019 |
| DOIs | |
| Publication status | Unpublished - 2019 |
Access to Document
- THESIS - DOCTOR OF PHILOSOPHY - CANNON Jeffrey William - 2019
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.